NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $2.48 per share for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2019-11-12
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-03-31 was $2.39, a 32.10% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2018-03-31 was $3.52, a 95.56% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2017-04-01 was $1.80.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $3.04.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2019-09-30 | $2.48 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $2.40 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | $2.39 10-Q · filed 2019-05-09 | |||
| 2018-09-30 | $2.92 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | $2.93 10-Q · filed 2018-08-09 | |||
| 2018-03-31 | $3.52 10-Q · filed 2018-05-10 | |||
| 2017-12-30 | $3.04 10-K · filed 2019-03-07 | |||
| 2017-09-30 | $1.88 10-Q · filed 2017-11-09 | |||
| 2017-07-01 | $1.85 10-Q · filed 2017-08-10 | |||
| 2017-04-01 | $1.80 10-Q · filed 2017-05-11 | |||
| 2016-10-01 | $2.71 10-Q · filed 2016-11-10 | |||
| 2016-07-02 | $3.16 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |